/ARDT
ARDT Stock - Ardent Health Partners, LLC
Healthcare|Medical - Care FacilitiesNYSE
$8.81-1.34%
$0.12 (-1.34%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+63.2%upside
Target: $14.38
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ARDT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$8.72 – $8.90
TARGET (TP)$14.38
STOP LOSS$8.11
RISK/REWARD1:8.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.76
52W High$17.34
52W Low$8.28
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $5.97B | $5.41B | $5.13B | $4.87B | $4.16B |
| Gross Profit | $4.93B | $5.27B | $4.17B | $3.94B | $4.16B |
| Gross Margin | 82.7% | 97.4% | 81.4% | 81.0% | 100.0% |
| Operating Income | $405.76M | $229.50M | $217.03M | $436.56M | $149.76M |
| Net Income | $210.34M | $50.29M | $188.91M | $154.26M | $-143,024,000 |
| Net Margin | 3.5% | 0.9% | 3.7% | 3.2% | -3.4% |
| EPS | $1.59 | $0.35 | $1.32 | $1.08 | $-1.01 |
Company Overview
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
8
57%
Hold / Neutral
5
36%
Sell / Underperform
1
7%
Analyst Consensus🟡 Mixed
8 Bullish6 Neutral/Bearish
Price Targets
$21
Average Target
↑ 134.5% Upside
Now
$15
Low
$21
Average
$27
High
Based on 16 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 17th 2025 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| November 14th 2025 | Morgan Stanley | Downgrade | Equal Weight | - |
| October 14th 2025 | Goldman | Initiation | Neutral | $19 |
| September 10th 2025 | UBS | Initiation | Buy | $17 |
| July 16th 2025 | BofA Securities | Downgrade | Underperform | $14.6 |
| December 17th 2024 | JP Morgan | Resumed | Neutral | $20 |
| November 6th 2024 | BofA Securities | Downgrade | Neutral | $19← $22 |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Overweight | $24 |
| August 12th 2024 | BofA Securities | Initiation | Buy | $22 |
| August 12th 2024 | Loop Capital | Initiation | Buy | $18 |
| August 12th 2024 | Stephens | Initiation | Overweight | $24 |
| August 12th 2024 | Citigroup | Initiation | Buy | $21 |
| August 12th 2024 | RBC Capital Mkts | Initiation | Outperform | $23 |
| August 12th 2024 | Morgan Stanley | Initiation | Overweight | $27 |
| August 12th 2024 | JP Morgan | Initiation | Neutral | $18 |
Earnings History & Surprises
ARDTBeat Rate
83%
Last 6 quarters
Avg Surprise
+27.7%
EPS vs Estimate
Beats / Misses
5/1
Last 12 quarters
Latest EPS
$0.52
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q3 24
+13.3%
$0.34vs$0.30
Q4 24
-43.3%
$0.17vs$0.30
Q1 25
+62.0%
$0.81vs$0.50
Q2 25
+38.1%
$0.29vs$0.21
Q3 25
+73.3%
$0.52vs$0.30
Q4 25
+22.6%
$0.52vs$0.42
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | $0.35 | — | — | — |
Q4 2025 | Nov 12, 2025 | $0.42 | $0.52 | +22.6% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $0.30 | $0.52 | +73.3% | ✓ BEAT |
Q2 2025 | May 6, 2025 | $0.21 | $0.29 | +38.1% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $0.50 | $0.81 | +62.0% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $0.30 | $0.17 | -43.3% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $0.30 | $0.34 | +13.3% | ✓ BEAT |
Q1 2024 | Mar 31, 2024 | — | $0.19 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.05 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.15 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.23 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.03 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-0.15 | — | — |
Q3 2018 | Sep 30, 2018 | — | $0.04 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.10 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.10 | — | — |
Q1 2017 | Mar 31, 2017 | — | $0.03 | — | — |
Q2 2015 | Jun 30, 2015 | — | $0.12 | — | — |
Q1 2015 | Mar 31, 2015 | — | $0.12 | — | — |
Latest News
UBS Maintains Buy on Ardent Health, Lowers Price Target to $14
➖ NeutralBenzinga•Dec 18, 2025, 03:27 PM•Also:
Mizuho Maintains Outperform on Ardent Health, Lowers Price Target to $12
➖ NeutralBenzinga•Dec 18, 2025, 01:11 PM
JP Morgan Maintains Neutral on Ardent Health, Lowers Price Target to $12
➖ NeutralBenzinga•Nov 24, 2025, 03:15 PM
Mizuho Maintains Outperform on Ardent Health, Lowers Price Target to $13
➖ NeutralBenzinga•Nov 18, 2025, 04:23 PM
Guggenheim Maintains Buy on Ardent Health, Lowers Price Target to $15
➖ NeutralBenzinga•Nov 18, 2025, 02:14 PM
Ardent Health Announces $50M Share Repurchase Program Authorization
📈 PositiveBenzinga•Nov 18, 2025, 01:03 PM
Keybanc Downgrades Ardent Health to Sector Weight
📉 NegativeBenzinga•Nov 17, 2025, 11:35 AM
RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $16
📈 PositiveBenzinga•Nov 14, 2025, 03:39 PM
Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $13
➖ NeutralBenzinga•Nov 14, 2025, 01:58 PM
Stephens & Co. Maintains Overweight on Ardent Health, Lowers Price Target to $17
➖ NeutralBenzinga•Nov 14, 2025, 01:35 PM
Morgan Stanley Downgrades Ardent Health to Equal-Weight, Lowers Price Target to $12
📉 NegativeBenzinga•Nov 14, 2025, 11:06 AM
B of A Securities Maintains Underperform on Ardent Health, Lowers Price Target to $10
📉 NegativeBenzinga•Nov 13, 2025, 05:41 PM
Ardent Health shares are trading lower after the company reported Q3 earnings below estimates and lowered its FY2025 GAAP EPS guidance.
📉 NegativeBenzinga•Nov 13, 2025, 12:17 PM
Ardent Health shares are trading lower after the company reported Q3 earnings below estimates and lowered its FY2025 GAAP EPS guidance.
📉 NegativeBenzinga•Nov 12, 2025, 09:37 PM
Ardent Health Lowers FY2025 GAAP EPS Guidance from $1.73-$2.01 to $0.85-$1.03 vs $1.85 Est; Affirms FY2025 Sales Guidance of $6.200B-$6.450B vs $6.346B Est
📉 NegativeBenzinga•Nov 12, 2025, 09:31 PM
Ardent Health Partners Q3 EPS $(0.17) Misses $0.41 Estimate, Sales $1.577B Beat $1.547B Estimate
📉 NegativeBenzinga•Nov 12, 2025, 09:31 PM
Goldman Sachs Initiates Coverage On Ardent Health with Neutral Rating, Announces Price Target of $19
➖ NeutralBenzinga•Oct 14, 2025, 12:50 PM•Also:
UBS Initiates Coverage On Ardent Health with Buy Rating, Announces Price Target of $17
📈 PositiveBenzinga•Sep 10, 2025, 10:47 AM
Ardent Health Files For Mixed Shelf Of Up To $500M
➖ NeutralBenzinga•Aug 21, 2025, 08:29 PM
Ardent Health trades lower as BofA Securities downgrades
📉 NegativeSeeking Alpha•Jul 16, 2025, 05:06 PM
Frequently Asked Questions about ARDT
What is ARDT's current stock price?
Ardent Health Partners, LLC (ARDT) is currently trading at $8.81 per share. The stock has moved -1.34% today.
What is the analyst price target for ARDT?
The average analyst price target for ARDT is $14.38, based on 1 analyst.
What sector is Ardent Health Partners, LLC in?
Ardent Health Partners, LLC operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NYSE exchange.
What is ARDT's market cap?
Ardent Health Partners, LLC has a market capitalization of $1.26 billion, making it a small-cap company.
Does ARDT pay dividends?
No, Ardent Health Partners, LLC does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHC
Acadia Healthcare Company, Inc.
$14.41
Mkt Cap: $1.3B
ADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
ASTH
Astrana Health, Inc.
$23.87
Mkt Cap: $1.2B
AVAH
Aveanna Healthcare Holdings Inc.
$9.09
Mkt Cap: $1.9B
BKD
Brookdale Senior Living Inc.
$10.79
Mkt Cap: $2.6B
IBRX
ImmunityBio, Inc.
$2.08
Mkt Cap: $2.0B
LFST
LifeStance Health Group, Inc.
$7.05
Mkt Cap: $2.7B
MD
Pediatrix Medical Group, Inc.
$21.91
Mkt Cap: $1.9B
NHC
National HealthCare Corporation
$141.64
Mkt Cap: $2.2B
SEM
Select Medical Holdings Corporation
$15.01
Mkt Cap: $1.9B
Explore stocks similar to ARDT for comparison